BrightSpring Health Services (BTSGU) Financials

$74.24 +0.68 (+0.92%)

As of 11:29 AM Eastern

Annual Income Statements for BrightSpring Health Services

This table shows BrightSpring Health Services' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-54	-155	-18
Consolidated Net Income / (Loss)	-54	-157	-21
Net Income / (Loss) Continuing Operations	-54	-157	-21
Total Pre-Tax Income	-46	-177	-35
Total Operating Income	188	147	206
Total Gross Profit	1,354	1,434	1,588
Total Revenue	7,721	8,826	11,266
Operating Revenue	7,721	8,826	11,266
Total Cost of Revenue	6,366	7,392	9,678
Operating Cost of Revenue	6,366	7,392	9,678
Total Operating Expenses	1,166	1,287	1,382
Selling, General & Admin Expense	1,126	1,287	1,382
Impairment Charge	41	0.00	0.00
Total Other Income / (Expense), net	-234	-325	-241
Interest Expense	234	325	241
Income Tax Expense	8.47	-21	-14
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.31	-2.23	-2.46
Basic Earnings per Share	($0.46)	($1.31)	($0.09)
Weighted Average Basic Shares Outstanding	117.84M	117.87M	193.00M
Diluted Earnings per Share	($0.46)	($1.31)	($0.09)
Weighted Average Diluted Shares Outstanding	117.84M	117.87M	193.00M
Weighted Average Basic & Diluted Shares Outstanding	-	-	174.97M

This table shows BrightSpring Health Services' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	-21	3.99	-131	-6.54	-46	20	-8.23	16
Consolidated Net Income / (Loss)	-22	2.77	-130	-7.20	-46	19	-8.98	15
Net Income / (Loss) Continuing Operations	-22	2.77	-130	-7.20	-46	19	-8.98	15
Total Pre-Tax Income	-27	-0.07	-136	-15	-70	9.98	0.78	24
Total Operating Income	52	80	-52	68	8.07	62	57	79
Total Gross Profit	335	372	358	369	369	389	408	422
Total Revenue	2,028	2,167	2,257	2,375	2,577	2,730	2,907	3,053
Operating Revenue	2,028	2,167	2,257	2,375	2,577	2,730	2,907	3,053
Total Cost of Revenue	1,694	1,795	1,898	2,006	2,207	2,341	2,499	2,631
Operating Cost of Revenue	1,694	1,795	1,898	2,006	2,207	2,341	2,499	2,631
Total Operating Expenses	283	292	411	300	361	327	351	343
Selling, General & Admin Expense	283	292	411	300	361	327	351	343
Total Other Income / (Expense), net	-78	-80	-84	-83	-78	-52	-56	-55
Interest Expense	78	80	84	83	78	52	56	55
Income Tax Expense	-4.35	-2.83	-5.81	-7.59	-23	-9.47	9.76	8.78
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.89	-1.22	0.55	-0.66	-0.64	-0.48	-0.75	-0.60
Basic Earnings per Share	($0.18)	$0.03	($1.11)	($0.05)	($0.26)	$0.10	($0.04)	$0.11
Weighted Average Basic Shares Outstanding	117.87M	117.88M	117.86M	117.87M	175.53M	197.52M	198.49M	193.00M
Diluted Earnings per Share	($0.18)	$0.03	($1.11)	($0.05)	($0.26)	$0.10	($0.04)	$0.11
Weighted Average Diluted Shares Outstanding	117.87M	126.45M	117.86M	117.87M	175.53M	208.99M	198.49M	193.00M
Weighted Average Basic & Diluted Shares Outstanding	-	-	-	0.00	171.32M	171.46M	174.13M	174.97M

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-33	-0.56	48
Net Cash From Operating Activities	-4.65	211	24
Net Cash From Continuing Operating Activities	-4.65	211	24
Net Income / (Loss) Continuing Operations	-54	-157	-21
Consolidated Net Income / (Loss)	-54	-157	-21
Depreciation Expense	204	202	204
Amortization Expense	20	21	12
Non-Cash Adjustments To Reconcile Net Income	78	38	124
Changes in Operating Assets and Liabilities, net	-252	107	-296
Net Cash From Investing Activities	45	-134	-140
Net Cash From Continuing Investing Activities	45	-134	-140
Purchase of Property, Plant & Equipment	-70	-74	-81
Acquisitions	-42	-63	-60
Divestitures	156	0.00	0.00
Other Investing Activities, net	2.14	2.15	0.47
Net Cash From Financing Activities	-74	-77	165
Net Cash From Continuing Financing Activities	-74	-77	165
Repayment of Debt	-41	-30	-3,443
Repurchase of Preferred Equity	0.00	-10	0.00
Repurchase of Common Equity	0.00	-0.65	-2.97
Payment of Dividends	-0.75	0.00	0.00
Issuance of Debt	-17	-24	2,968
Issuance of Common Equity	0.23	1.33	658
Other Financing Activities, net	-15	-13	-15
Cash Interest Paid	213	304	211
Cash Income Taxes Paid	29	37	25

This table details how cash moves in and out of BrightSpring Health Services' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	-2.45	0.08	0.39	1.43	45	-33	11	25
Net Cash From Operating Activities	40	-25	34	162	-79	-15	27	91
Net Cash From Continuing Operating Activities	40	-25	34	162	-79	-15	27	91
Net Income / (Loss) Continuing Operations	-22	2.77	-130	-7.20	-46	19	-8.98	15
Consolidated Net Income / (Loss)	-22	2.77	-130	-7.20	-46	19	-8.98	15
Depreciation Expense	50	50	51	51	49	50	51	55
Amortization Expense	5.20	5.31	5.18	5.23	4.45	2.49	2.54	2.63
Non-Cash Adjustments To Reconcile Net Income	10	10	9.62	7.49	46	21	27	30
Changes in Operating Assets and Liabilities, net	-3.39	-94	98	106	-132	-108	-44	-12
Net Cash From Investing Activities	-17	-45	-55	-17	-31	-58	-36	-16
Net Cash From Continuing Investing Activities	-17	-45	-55	-17	-31	-58	-36	-16
Purchase of Property, Plant & Equipment	-18	-21	-18	-17	-22	-24	-20	-15
Acquisitions	0.00	-25	-37	-0.55	-9.39	-34	-16	-0.04
Other Investing Activities, net	0.38	1.11	0.30	0.36	0.27	0.27	0.36	-0.43
Net Cash From Financing Activities	-25	71	21	-144	155	40	20	-50
Net Cash From Continuing Financing Activities	-25	71	21	-144	155	40	20	-50
Repayment of Debt	-22	6.76	-7.54	-7.58	-887	-2,527	-14	-16
Issuance of Debt	0.00	67	32	-122	389	2,571	41	-34
Issuance of Common Equity	0.09	0.06	0.45	0.74	656	0.40	0.13	1.00
Other Financing Activities, net	-2.89	-2.84	-2.90	-4.42	-3.08	-4.13	-6.22	-1.20
Cash Interest Paid	73	74	78	78	60	51	54	46
Cash Income Taxes Paid	3.73	23	9.08	1.86	11	13	0.62	0.64

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2023	2024
Period end date	12/31/2023	12/31/2024
Total Assets	5,533	5,926
Total Current Assets	1,457	1,893
Cash & Equivalents	13	61
Accounts Receivable	882	1,029
Inventories, net	403	641
Prepaid Expenses	159	163
Plant, Property, & Equipment, net	246	250
Total Noncurrent Assets	3,830	3,783
Goodwill	2,608	2,672
Intangible Assets	881	811
Noncurrent Deferred & Refundable Income Taxes	0.00	5.58
Other Noncurrent Operating Assets	340	294
Total Liabilities & Shareholders' Equity	5,533	5,926
Total Liabilities	4,920	4,275
Total Current Liabilities	1,248	1,428
Short-Term Debt	32	49
Accounts Payable	642	941
Accrued Expenses	492	357
Other Current Liabilities	82	82
Total Noncurrent Liabilities	3,672	2,846
Long-Term Debt	3,332	2,562
Capital Lease Obligations	224	25
Noncurrent Deferred & Payable Income Tax Liabilities	24	0.00
Other Noncurrent Operating Liabilities	92	259
Redeemable Noncontrolling Interest	27	3.73
Total Equity & Noncontrolling Interests	585	1,648
Total Preferred & Common Equity	585	1,648
Preferred Stock	0.00	0.00
Total Common Equity	585	1,648
Common Stock	773	1,869
Retained Earnings	-200	-222
Accumulated Other Comprehensive Income / (Loss)	13	1.42
Noncontrolling Interest	0.67	0.00

This table presents BrightSpring Health Services' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024
Period end date	3/31/2024	6/30/2024	9/30/2024
Total Assets	5,656	5,605	5,786
Total Current Assets	1,573	1,522	1,710
Cash & Equivalents	58	25	36
Accounts Receivable	991	985	1,026
Inventories, net	374	374	478
Prepaid Expenses	150	138	170
Plant, Property, & Equipment, net	246	246	249
Total Noncurrent Assets	3,837	3,838	3,828
Goodwill	2,609	2,626	2,673
Intangible Assets	856	851	842
Noncurrent Deferred & Refundable Income Taxes	11	22	6.68
Other Noncurrent Operating Assets	361	338	306
Total Liabilities & Shareholders' Equity	5,656	5,605	5,786
Total Liabilities	4,081	3,999	4,167
Total Current Liabilities	1,245	1,145	1,264
Short-Term Debt	49	49	49
Accounts Payable	656	669	784
Accrued Expenses	452	347	349
Other Current Liabilities	89	80	82
Total Noncurrent Liabilities	2,836	2,854	2,903
Long-Term Debt	2,515	2,564	2,609
Capital Lease Obligations	24	220	221
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	0.00	0.00
Other Noncurrent Operating Liabilities	297	71	74
Redeemable Noncontrolling Interest	6.28	5.94	4.13
Total Equity & Noncontrolling Interests	1,568	1,600	1,615
Total Preferred & Common Equity	1,567	1,600	1,615
Preferred Stock	0.00	0.00	0.00
Total Common Equity	1,567	1,600	1,615
Common Stock	1,790	1,807	1,850
Retained Earnings	-246	-226	-234
Accumulated Other Comprehensive Income / (Loss)	23	19	-0.71
Noncontrolling Interest	0.52	0.38	0.20

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	0.00%	14.32%	27.65%
EBITDA Growth	0.00%	-10.14%	14.18%
EBIT Growth	0.00%	-21.64%	40.22%
NOPAT Growth	0.00%	-21.64%	40.22%
Net Income Growth	0.00%	-189.26%	86.92%
EPS Growth	0.00%	-184.78%	93.13%
Operating Cash Flow Growth	0.00%	4,630.05%	-88.72%
Free Cash Flow Firm Growth	0.00%	0.00%	102.61%
Invested Capital Growth	0.00%	0.00%	0.91%
Revenue Q/Q Growth	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	-5.28%
Profitability Metrics	-	-	-
Gross Margin	17.54%	16.24%	14.10%
EBITDA Margin	5.34%	4.20%	3.75%
Operating Margin	2.43%	1.67%	1.83%
EBIT Margin	2.43%	1.67%	1.83%
Profit (Net Income) Margin	-0.70%	-1.78%	-0.18%
Tax Burden Percent	118.50%	88.40%	59.07%
Interest Burden Percent	-24.36%	-120.54%	-16.83%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	4.92%	3.43%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-9.62%	-1.93%
Return on Net Nonoperating Assets (RNNOA)	0.00%	-56.13%	-5.25%
Return on Equity (ROE)	0.00%	-51.21%	-1.81%
Cash Return on Invested Capital (CROIC)	0.00%	-195.08%	2.53%
Operating Return on Assets (OROA)	0.00%	2.66%	3.60%
Return on Assets (ROA)	0.00%	-2.83%	-0.36%
Return on Common Equity (ROCE)	0.00%	-48.88%	-1.79%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-26.82%	-1.25%
Net Operating Profit after Tax (NOPAT)	131	103	144
NOPAT Margin	1.70%	1.17%	1.28%
Net Nonoperating Expense Percent (NNEP)	0.00%	14.54%	5.37%
Return On Investment Capital (ROIC_SIMPLE)	-	2.47%	3.37%
Cost of Revenue to Revenue	82.46%	83.76%	85.90%
SG&A Expenses to Revenue	14.58%	14.58%	12.27%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	15.11%	14.58%	12.27%
Earnings before Interest and Taxes (EBIT)	188	147	206
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	412	370	423
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.00	1.19	1.80
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.09	0.08	0.26
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	1.03	1.31
Enterprise Value to Revenue (EV/Rev)	0.00	0.49	0.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	11.60	13.11
Enterprise Value to EBIT (EV/EBIT)	0.00	29.19	26.86
Enterprise Value to NOPAT (EV/NOPAT)	0.00	41.70	38.37
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	20.38	233.17
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	52.08
Leverage & Solvency	-	-	-
Debt to Equity	0.00	5.86	1.60
Long-Term Debt to Equity	0.00	5.81	1.57
Financial Leverage	0.00	5.84	2.72
Leverage Ratio	0.00	9.03	5.06
Compound Leverage Factor	0.00	-10.89	-0.85
Debt to Total Capital	0.00%	85.42%	61.48%
Short-Term Debt to Total Capital	0.00%	0.77%	1.14%
Long-Term Debt to Total Capital	0.00%	84.65%	60.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.66%	0.09%
Common Equity to Total Capital	0.00%	13.92%	38.44%
Debt to EBITDA	0.00	9.69	6.23
Net Debt to EBITDA	0.00	9.65	6.09
Long-Term Debt to EBITDA	0.00	9.60	6.12
Debt to NOPAT	0.00	34.83	18.24
Net Debt to NOPAT	0.00	34.70	17.82
Long-Term Debt to NOPAT	0.00	34.52	17.91
Altman Z-Score	0.00	1.76	2.47
Noncontrolling Interest Sharing Ratio	0.00%	4.54%	1.39%
Liquidity Ratios	-	-	-
Current Ratio	0.00	1.17	1.33
Quick Ratio	0.00	0.72	0.76
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-4,085	106
Operating Cash Flow to CapEx	-6.64%	286.67%	29.38%
Free Cash Flow to Firm to Interest Expense	0.00	-12.58	0.44
Operating Cash Flow to Interest Expense	-0.02	0.65	0.10
Operating Cash Flow Less CapEx to Interest Expense	-0.32	0.42	-0.24
Efficiency Ratios	-	-	-
Asset Turnover	0.00	1.60	1.97
Accounts Receivable Turnover	0.00	10.01	11.80
Inventory Turnover	0.00	18.35	18.55
Fixed Asset Turnover	0.00	35.89	45.41
Accounts Payable Turnover	0.00	11.52	12.23
Days Sales Outstanding (DSO)	0.00	36.46	30.94
Days Inventory Outstanding (DIO)	0.00	19.89	19.67
Days Payable Outstanding (DPO)	0.00	31.68	29.85
Cash Conversion Cycle (CCC)	0.00	24.67	20.77
Capital & Investment Metrics	-	-	-
Invested Capital	0.00	4,188	4,226
Invested Capital Turnover	0.00	4.22	2.68
Increase / (Decrease) in Invested Capital	0.00	4,188	38
Enterprise Value (EV)	0.00	4,296	5,543
Market Capitalization	693	693	2,965
Book Value per Share	$0.00	$4.96	$9.46
Tangible Book Value per Share	$0.00	($24.65)	($10.54)
Total Capital	0.00	4,201	4,287
Total Debt	0.00	3,588	2,636
Total Long-Term Debt	0.00	3,556	2,587
Net Debt	0.00	3,575	2,574
Capital Expenditures (CapEx)	70	74	81
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	227	452
Debt-free Net Working Capital (DFNWC)	0.00	240	513
Net Working Capital (NWC)	0.00	208	465
Net Nonoperating Expense (NNE)	186	260	165
Net Nonoperating Obligations (NNO)	0.00	3,575	2,574
Total Depreciation and Amortization (D&A)	224	223	217
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	2.58%	4.01%
Debt-free Net Working Capital to Revenue	0.00%	2.72%	4.56%
Net Working Capital to Revenue	0.00%	2.36%	4.12%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	($0.09)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	193.00M
Adjusted Diluted Earnings per Share	$0.00	$0.00	($0.09)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	193.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	174.97M
Normalized Net Operating Profit after Tax (NOPAT)	160	103	144
Normalized NOPAT Margin	2.07%	1.17%	1.28%
Pre Tax Income Margin	-0.59%	-2.01%	-0.31%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.80	0.45	0.86
NOPAT to Interest Expense	0.56	0.32	0.60
EBIT Less CapEx to Interest Expense	0.50	0.23	0.52
NOPAT Less CapEx to Interest Expense	0.26	0.09	0.26
Payout Ratios	-	-	-
Dividend Payout Ratio	-1.38%	0.00%	0.00%
Augmented Payout Ratio	-1.38%	-0.41%	-14.45%

This table displays calculated financial ratios and metrics derived from BrightSpring Health Services' official financial filings.

Metric	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	27.03%	26.01%	28.82%	28.56%
EBITDA Growth	0.00%	0.00%	0.00%	0.00%	-42.64%	-14.92%	2,870.24%	9.69%
EBIT Growth	0.00%	0.00%	0.00%	0.00%	-84.35%	-21.61%	208.78%	15.81%
NOPAT Growth	0.00%	0.00%	0.00%	0.00%	-84.35%	118.27%	-1,691.56%	5.36%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	-108.23%	602.86%	93.10%	313.91%
EPS Growth	0.00%	0.00%	0.00%	0.00%	-44.44%	233.33%	96.40%	320.00%
Operating Cash Flow Growth	0.00%	0.00%	0.00%	0.00%	-297.66%	39.59%	-19.13%	-44.20%
Free Cash Flow Firm Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.91%
Revenue Q/Q Growth	0.00%	6.82%	4.14%	5.23%	0.00%	5.96%	6.47%	5.02%
EBITDA Q/Q Growth	0.00%	26.18%	-97.26%	3,262.11%	0.00%	87.15%	-4.34%	24.16%
EBIT Q/Q Growth	0.00%	54.43%	-165.63%	230.64%	0.00%	673.70%	-8.93%	39.08%
NOPAT Q/Q Growth	0.00%	54.43%	-165.63%	230.64%	0.00%	2,054.16%	-638.71%	107.68%
Net Income Q/Q Growth	0.00%	112.42%	-4,804.41%	94.47%	0.00%	141.91%	-146.20%	271.52%
EPS Q/Q Growth	0.00%	116.67%	-3,800.00%	95.50%	0.00%	138.46%	-140.00%	375.00%
Operating Cash Flow Q/Q Growth	0.00%	-163.17%	233.67%	382.03%	0.00%	80.69%	278.96%	232.57%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	-4.69%	-19.24%	100.24%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	7.51%	1.10%	-5.28%
Profitability Metrics	-	-	-	-	-	-	-	-
Gross Margin	16.50%	17.17%	15.88%	15.53%	14.34%	14.25%	14.04%	13.82%
EBITDA Margin	5.28%	6.24%	0.16%	5.24%	2.38%	4.21%	3.78%	4.47%
Operating Margin	2.54%	3.67%	-2.32%	2.87%	0.31%	2.29%	1.96%	2.59%
EBIT Margin	2.54%	3.67%	-2.32%	2.87%	0.31%	2.29%	1.96%	2.59%
Profit (Net Income) Margin	-1.10%	0.13%	-5.77%	-0.30%	-1.80%	0.71%	-0.31%	0.50%
Tax Burden Percent	83.68%	-4,067.65%	95.73%	48.68%	66.57%	194.90%	-1,152.89%	63.69%
Interest Burden Percent	-51.64%	-0.09%	260.14%	-21.67%	-863.75%	15.98%	1.37%	30.60%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	-94.90%	1,252.89%	36.31%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	4.24%	0.00%	0.00%	0.00%	4.42%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	2.70%	0.00%	0.00%	0.00%	3.28%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	15.78%	0.00%	0.00%	0.00%	8.91%
Return on Equity (ROE)	0.00%	0.00%	0.00%	20.02%	0.00%	0.00%	0.00%	13.33%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	-97.54%	0.00%	0.00%	0.00%	2.53%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	4.59%	0.00%	0.00%	0.00%	5.09%
Return on Assets (ROA)	0.00%	0.00%	0.00%	-0.48%	0.00%	0.00%	0.00%	0.99%
Return on Common Equity (ROCE)	0.00%	0.00%	0.00%	19.11%	0.00%	0.00%	0.00%	13.14%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	36	56	-37	48	5.65	122	-655	50
NOPAT Margin	1.78%	2.57%	-1.62%	2.01%	0.22%	4.46%	-22.54%	1.65%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.00%	0.00%	1.54%	4.11%	7.28%	-45.48%	1.14%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	1.14%	-	-	-	1.18%
Cost of Revenue to Revenue	83.50%	82.83%	84.12%	84.47%	85.66%	85.75%	85.96%	86.18%
SG&A Expenses to Revenue	13.96%	13.50%	18.19%	12.65%	14.02%	11.96%	12.08%	11.23%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	13.96%	13.50%	18.19%	12.65%	14.02%	11.96%	12.08%	11.23%
Earnings before Interest and Taxes (EBIT)	52	80	-52	68	8.07	62	57	79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	107	135	3.70	124	61	115	110	137
Valuation Ratios	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	0.00	1.19	0.37	1.22	1.56	1.80
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	0.08	0.00	0.00	0.00	0.26
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	1.03	0.76	1.08	1.20	1.31
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.49	0.00	0.00	0.00	0.49
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	11.60	0.00	0.00	0.00	13.11
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	29.19	0.00	0.00	0.00	26.86
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	41.70	0.00	0.00	0.00	38.37
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	20.38	0.00	0.00	0.00	233.17
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	52.08
Leverage & Solvency	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	5.86	1.64	1.76	1.78	1.60
Long-Term Debt to Equity	0.00	0.00	0.00	5.81	1.61	1.73	1.75	1.57
Financial Leverage	0.00	0.00	0.00	5.84	1.61	1.75	1.76	2.72
Leverage Ratio	0.00	0.00	0.00	9.03	3.59	3.49	3.57	5.06
Compound Leverage Factor	0.00	0.00	0.00	-1.96	-31.03	0.56	0.05	1.55
Debt to Total Capital	0.00%	0.00%	0.00%	85.42%	62.18%	63.81%	64.00%	61.48%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.77%	1.17%	1.10%	1.09%	1.14%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	84.65%	61.01%	62.72%	62.91%	60.34%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.66%	0.16%	0.14%	0.10%	0.09%
Common Equity to Total Capital	0.00%	0.00%	0.00%	13.92%	37.66%	36.04%	35.90%	38.44%
Debt to EBITDA	0.00	0.00	0.00	9.69	0.00	0.00	0.00	6.23
Net Debt to EBITDA	0.00	0.00	0.00	9.65	0.00	0.00	0.00	6.09
Long-Term Debt to EBITDA	0.00	0.00	0.00	9.60	0.00	0.00	0.00	6.12
Debt to NOPAT	0.00	0.00	0.00	34.83	0.00	0.00	0.00	18.24
Net Debt to NOPAT	0.00	0.00	0.00	34.70	0.00	0.00	0.00	17.82
Long-Term Debt to NOPAT	0.00	0.00	0.00	34.52	0.00	0.00	0.00	17.91
Altman Z-Score	0.00	0.00	0.00	1.72	0.10	0.35	0.43	2.40
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	4.54%	0.43%	0.39%	0.27%	1.39%
Liquidity Ratios	-	-	-	-	-	-	-	-
Current Ratio	0.00	0.00	0.00	1.17	1.26	1.33	1.35	1.33
Quick Ratio	0.00	0.00	0.00	0.72	0.84	0.88	0.84	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	0.00	0.00	0.00	-4,099	-4,291	-5,117	12
Operating Cash Flow to CapEx	223.56%	-120.32%	188.23%	964.71%	-361.47%	-64.12%	135.94%	591.81%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	-52.72	-81.83	-91.27	0.22
Operating Cash Flow to Interest Expense	0.51	-0.32	0.40	1.96	-1.01	-0.29	0.49	1.65
Operating Cash Flow Less CapEx to Interest Expense	0.28	-0.58	0.19	1.75	-1.29	-0.74	0.13	1.37
Efficiency Ratios	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	1.60	0.00	0.00	0.00	1.97
Accounts Receivable Turnover	0.00	0.00	0.00	10.01	0.00	0.00	0.00	11.80
Inventory Turnover	0.00	0.00	0.00	18.35	0.00	0.00	0.00	18.55
Fixed Asset Turnover	0.00	0.00	0.00	35.89	0.00	0.00	0.00	45.41
Accounts Payable Turnover	0.00	0.00	0.00	11.52	0.00	0.00	0.00	12.23
Days Sales Outstanding (DSO)	0.00	0.00	0.00	36.46	0.00	0.00	0.00	30.94
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	19.89	0.00	0.00	0.00	19.67
Days Payable Outstanding (DPO)	0.00	0.00	0.00	31.68	0.00	0.00	0.00	29.85
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	24.67	0.00	0.00	0.00	20.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-
Invested Capital	0.00	0.00	0.00	4,188	4,104	4,413	4,461	4,226
Invested Capital Turnover	0.00	0.00	0.00	2.11	0.00	0.00	0.00	2.68
Increase / (Decrease) in Invested Capital	0.00	0.00	0.00	0.00	4,104	4,413	4,461	38
Enterprise Value (EV)	0.00	0.00	0.00	4,296	3,117	4,759	5,364	5,543
Market Capitalization	693	693	693	693	580	1,946	2,517	2,965
Book Value per Share	$0.00	$0.00	$0.00	$4.96	$8.93	$9.34	$9.42	$9.46
Tangible Book Value per Share	$0.00	$0.00	$0.00	($24.65)	($10.81)	($10.96)	($11.08)	($10.54)
Total Capital	0.00	0.00	0.00	4,201	4,163	4,438	4,497	4,287
Total Debt	0.00	0.00	0.00	3,588	2,588	2,832	2,878	2,636
Total Long-Term Debt	0.00	0.00	0.00	3,556	2,540	2,783	2,829	2,587
Net Debt	0.00	0.00	0.00	3,575	2,530	2,807	2,842	2,574
Capital Expenditures (CapEx)	18	21	18	17	22	24	20	15
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	0.00	0.00	227	318	400	459	452
Debt-free Net Working Capital (DFNWC)	0.00	0.00	0.00	240	376	426	495	513
Net Working Capital (NWC)	0.00	0.00	0.00	208	328	377	446	465
Net Nonoperating Expense (NNE)	58	53	94	55	52	102	-646	35
Net Nonoperating Obligations (NNO)	0.00	0.00	0.00	3,575	2,530	2,807	2,842	2,574
Total Depreciation and Amortization (D&A)	56	56	56	56	53	53	53	58
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	2.58%	0.00%	0.00%	0.00%	4.01%
Debt-free Net Working Capital to Revenue	0.00%	0.00%	0.00%	2.72%	0.00%	0.00%	0.00%	4.56%
Net Working Capital to Revenue	0.00%	0.00%	0.00%	2.36%	0.00%	0.00%	0.00%	4.12%
Earnings Adjustments	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$0.00	($0.05)	($0.26)	$0.10	($0.04)	$0.11
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	0.00	117.87M	175.53M	197.52M	198.49M	193.00M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$0.00	($0.05)	($0.26)	$0.10	($0.04)	$0.11
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	0.00	117.87M	175.53M	208.99M	198.49M	193.00M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	0.00	0.00	171.32M	171.46M	174.13M	174.97M
Normalized Net Operating Profit after Tax (NOPAT)	36	56	-37	48	5.65	44	40	50
Normalized NOPAT Margin	1.78%	2.57%	-1.62%	2.01%	0.22%	1.60%	1.37%	1.65%
Pre Tax Income Margin	-1.31%	0.00%	-6.02%	-0.62%	-2.70%	0.37%	0.03%	0.79%
Debt Service Ratios	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.66	1.00	-0.62	0.82	0.10	1.19	1.01	1.44
NOPAT to Interest Expense	0.46	0.70	-0.44	0.58	0.07	2.32	-11.69	0.92
EBIT Less CapEx to Interest Expense	0.43	0.74	-0.84	0.62	-0.18	0.74	0.66	1.16
NOPAT Less CapEx to Interest Expense	0.23	0.44	-0.65	0.37	-0.21	1.87	-12.05	0.64
Payout Ratios	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	-0.41%	0.00%	0.00%	0.00%	-14.45%

Frequently Asked Questions About BrightSpring Health Services' Financials

When does BrightSpring Health Services's financial year end?

According to the most recent income statement we have on file, BrightSpring Health Services' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has BrightSpring Health Services' net income changed over the last 2 years?

BrightSpring Health Services' net income appears to be on a downward trend, with a most recent value of -$20.52 million in 2024, falling from -$54.22 million in 2022. The previous period was -$156.84 million in 2023.

What is BrightSpring Health Services's operating income?

BrightSpring Health Services's total operating income in 2024 was $206.37 million, based on the following breakdown:

Total Gross Profit: $1.59 billion
Total Operating Expenses: $1.38 billion

How has BrightSpring Health Services revenue changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' total revenue changed from $7.72 billion in 2022 to $11.27 billion in 2024, a change of 45.9%.

How much debt does BrightSpring Health Services have?

BrightSpring Health Services' total liabilities were at $4.27 billion at the end of 2024, a 13.1% decrease from 2023, and a 13.1% decrease since 2023.

How much cash does BrightSpring Health Services have?

In the past 1 years, BrightSpring Health Services' cash and equivalents has ranged from $13.07 million in 2023 to $61.25 million in 2024, and is currently $61.25 million as of their latest financial filing in 2024.

How has BrightSpring Health Services' book value per share changed over the last 2 years?

Over the last 2 years, BrightSpring Health Services' book value per share changed from 0.00 in 2022 to 9.46 in 2024, a change of 946.4%.

Related Companies

This page (NASDAQ:BTSGU) was last updated on 5/5/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

BrightSpring Health Services (BTSGU) Financials

Frequently Asked Questions About BrightSpring Health Services' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

BrightSpring Health Services (BTSGU) Financials

Annual Income Statements for BrightSpring Health Services

Quarterly Income Statements for BrightSpring Health Services

Annual Cash Flow Statements for BrightSpring Health Services

Quarterly Cash Flow Statements for BrightSpring Health Services

Annual Balance Sheets for BrightSpring Health Services

Quarterly Balance Sheets for BrightSpring Health Services

Annual Metrics and Ratios for BrightSpring Health Services

Quarterly Metrics and Ratios for BrightSpring Health Services

Frequently Asked Questions About BrightSpring Health Services' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools